Situation of the Prescription service

Situation of the Prescription service

The situation of the joint testing of the Prescription service is compiled on this page. Tabulating starts from joint tests completed on 29 April 2016.

Read more about the requirements for taking part in joint testing on the Kanta Services website:

Situation of the Prescription service

Ongoing joint testings

No ongoing joint testings

Table: Abilita Hälsovård / Abilita Oy Ab accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20102016 / 30.12.2016
Functionality for action on behalf of a minor

20072020 / 14.9.2020
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20122022 / 8.2.2022
The 2022 changes of the Pharmaceutical Database 20022023 / 1.2.2023

Ongoing joint testings

No ongoing joint testings

Table: Acute / Vitec Acute Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information 20012016 / 30.11.2016
Functionality for action on behalf of a minor 20072021 / 14.9.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20032022 / 3.2.2022
The 2022 changes of the Pharmaceutical Database 20272022 / 5.10.2022

Ongoing joint testings

No ongoing joint testings

Table: Altti2 / Fujitsu Finland Oy accepted joint testings
Accepted joint testings Statement number and date
Joint testing of the Prescription service

20142023 / 29.5.2023

Ongoing joint testings

No ongoing joint testings

Table: Apotti (Epic) / Apotti Oy accepted joint testing
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.42 and requirement specifications 2.9, Refusal to share prescription information

20022018 / 5.10.2018
Functionality for action on behalf of a minor 2.5.2022 / 20192022
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database (Prescription's HL7 specifications 3.42) 29.4.2022 / 20182022
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database (Prescription's HL7 specifications 3.63) 5.5.2022 / 20212022
The 2022 changes of the Pharmaceutical Database 20032023 / 25.1.2023

Ongoing joint testings

No ongoing joint testings

Table: AssisDent / Entteri Professional Software Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20062016 / 27.12.2016
Functionality for action on behalf of a minor 20062021 / 30.6.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 27.4.2022 / 20162022
The 2022 changes of the Pharmaceutical Database 20052023 / 8.3.2023
Testing of interoperability (Testing of system changes) 20182023 / 25.8.2023
Table: DomaCare / Invian Oy ongoing joint testings
Ongoing joint testings Registration, return date of pre-test cases Testing between system supplier and Kela Testing between client test organisation and Kela Cross-testing
The 2022 changes of the Pharmaceutical Database 17.11.2022 Ongoing, 21.11.2022 Not tested Not tested

Table: DomaCare / Invian Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9

20142017 / 7.3.2017
Functionality for action on behalf of a minor 20032021 / 4.5.2021
Refusal to share prescription information 20052021 / 29.6.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 29.4.2022 / 20172022

Ongoing joint testings

No ongoing joint testings

Table: DynamicHealth / TietoEVRY Oyj accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20032016 / 30.12.2016
Functionality for action on behalf of a minor

20122020 / 20.11.2020
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20022022 / 2.2.2022
The 2022 changes of the Pharmaceutical Database 20042023 / 2.2.2023
Prescription's MR and CDA R2 specifications 4.00 and requirement specifications 3.00 (DynamicHealth eResepti Interface) 20112023 / 26.4.2023

Ongoing joint testings

No ongoing joint testings

Table: Effica / TietoEVRY Oyj accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20032016 / 9.12.2016

Ongoing joint testings

No ongoing joint testings

Table: ERA / Atostek Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20092016 / 29.12.2016
​​Functionality for action on behalf of a minor

20032020 / 16.3.2020
​Functionality for action on behalf of a minor (testing of system changes)

20052020 / 10.8.2020
The ​2022 version of the Pharmaceutical Database 20102022 / 11.4.2022
​Structured dosage 20112022 / 12.4.2022
FHIR interface to search for identifiers 20082022 / 22.3.2022

Ongoing joint testings

No ongoing joint testings

Table: ESKO / Esko Systems Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20022016 / 9.12.2016
Functionality for action on behalf of a minor 20012022 / 31.1.2022
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database  20132022 / 11.4.2022 
The 2022 changes of the Pharmaceutical Database 20302022 / 27.10.2022

Ongoing joint testings

No ongoing joint testings

Table: Hilkka / FastROI Oy a joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9

20082016 / 30.12.2016
Refusal to share prescription information

20012018 / 11.1.2018
Functionality for action on behalf of a minor 20022021 / 12.4.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 26.4.2022 / 20152022
The 2022 version of the Pharmaceutical Database 20072023 / 4.4.2023
Structured dosage 20132023 / 11.5.2023

Ongoing joint testings

No ongoing joint testings

Table: KEJO / PCC-ryhmittymä accepted joint testings
Accepted joint testings Statement number and date
Search and viewing of data concerning prescriptions and dispensations

20142020 / 23.11.2022

Ongoing joint testings

No ongoing joint testings

Table: Kelain / Kela accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9   

20042016 / 13.12.2016
Refusal to share prescription information

20202017 / 1.6.2017
Functionality for action on behalf of a minor

20012020 / 14.1.2020
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20042022 / 3.2.2022
The 2022 changes of the Pharmaceutical Database 20282022 / 13.10.2022
 
Structured dosage 20292022 / 13.10.2022

Ongoing joint testings

No ongoing joint testings

Table: Lifecare / TietoEVRY Oyj accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20192017 / 11.5.2017
Functionality for action on behalf of a minor 20102021 / 18.11.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20062022 / 23.2.2022
The 2022 version of the Pharmaceutical Database 20062023 / 24.3.2023
​Structured dosage 20152023 / 2.6.2023
FHIR interface to search for identifiers 20162023 / 13.6.2023

Ongoing joint testings

No ongoing joint testings

Table: MAXX / Receptum Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20122017 / 11.1.2017
Cross-border prescription

20012019 / 30.9.2019
Functionality for action on behalf of a minor

20062020 / 8.9.2020
The ​2022 changes of the Pharmaceutical Database 20252022 / 29.4.2022
​Structured dosage 20262022 / 29.4.2022
Code identifying a prescribed medicine at the pharmacy 20082023 / 13.4.2023

Ongoing joint testings

No ongoing joint testings

Table: Mediatri / Mediconsult Oy accepted joint testings
Accepted joint testings Statement number and date

Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9

20072016 / 30.12.2016
Refusal to share prescription information

20212017 / 6.6.2017
Functionality for action on behalf of a minor   

20042020 / 8.10.2020
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 17.2.2022 / 20072022
The 2022 changes of the Pharmaceutical Database 20322022 / 28.11.2022

Ongoing joint testings

No ongoing joint testings

Table: Mediatri Saga / Mediconsult Oyj accepted joint testings
Accepted joint testings Statement number and date
Prescription's HL7 specifications 3.63 and functional specification 2.94

20312022 / 4.11.2022
The 2022 version of the Pharmaceutical Database 20172023 / 16.8.2023

Ongoing joint testings

No ongoing joint testings

Table: Mediresepti / Mediconsult Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9

20132016 / 30.12.2016
Refusal to share prescription information

20222017 / 4.12.2017
Functionality for action on behalf of a minor

20132020 / 26.11.2020
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20092022 / 22.3.2022 
The 2022 version of the Pharmaceutical Database 20192023 / 13.10.2023

Ongoing joint testings

No ongoing joint testings

Table: Navitas / Elisa Appelsiini Oy accepted joint testings
Accepted joint testings Statement number and date
Refusal to share prescription information   

20182017 / 24.2.2017
Table: Norre / Norre Työterveys Oy ongoing joint testings
Ongoing joint testings Registration, return date of pre-test cases Testing between system supplier and Kela Testing between client test organisation and Kela Cross-testing

Prescription's MR and CDA R2 specifications 4.0 and requirement specifications 3.0

 25.8.2022 Discontinued Not started Not started

Ongoing joint testings

No ongoing joint testings

Table: Omapd / Pharmadata Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 4.0 and requirement specifications 3.0 20012023 / 1.2.2023
Code identifying a prescribed medicine at the pharmacy 20102023 / 26.4.2023

Ongoing joint testings

No ongoing joint testings

Table: OMNI360 Terveydenhuolto (Pegasos OMNI360 Kertomus) / CGI Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20052016 / 20.12.2016
Functionality for action on behalf of a minor (OMNI360 Kertomus)

20012021 / 21.1.2021
Functionality for action on behalf of a minor 20082021 / 14.9.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database (OMNI360 Kertomus) 20122021 / 18.11.2021
Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database 20052022 / 24.2.2022
The 2022 changes of the Pharmaceutical Database (OMNI360 Kertomus) 20342022 / 20.12.2022

Ongoing joint testings

No ongoing joint testings

Table: pd3 / Pharmadata Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20172017 / 27.1.2017

Cross-border prescription

20022020 / 20.2.2020
Functionality for action on behalf of a minor

20102020 / 24.9.2020
Structured dosage 3.5.2022 / 20242022
The 2022 changes of the Pharmaceutical Database​ 3.5.2022 / 20232022
Code identifying a prescribed medicine at the pharmacy 20092023 / 26.4.2023

Ongoing joint testings

No ongoing joint testings

Table: Sairec / CGI Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 4.1.1 and requirement specifications 3.1.1

20202023 / 20.10.2023

Ongoing joint testings

No ongoing joint testings

Table: Salix / Pharmadata Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20162017 / 27.1.2017
Cross-border prescription

20022019 / 10.12.2019
Functionality for action on behalf of a minor

20092020 / 24.9.2020
​Structured dosage 20222022 / 3.5.2022
The ​2022 changes of the Pharmaceutical Database 20202022 / 3.5.2022
Code identifying a prescribed medicine at the pharmacy 20122023 / 27.4.2023

Ongoing joint testings

No ongoing joint testings

Table: Uranus / CGI Oy accepted joint testings
Accepted joint testings Statement number and date
Prescription's MR and CDA R2 specifications 3.41/3.42 and requirement specifications 2.8/2.9, Refusal to share prescription information

20152017 / 11.1.2017

 
Functionality for action on behalf of a minor 20042021 / 16.6.2021
​​Forward compatibility of the structured dosage and the 2022 version of the Pharmaceutical Database

20112021 / 18.11.2021
The 2022 changes of the Pharmaceutical Database 20332022 / 20.12.2022
Last updated 17.10.2024